Browse
Submit Data
Databases
API
Help

Dataset Information

11 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression changes upon treatment of T47D breast cancer cells with the Pan-PI3 kinase inhibitor GDC-0941

ABSTRACT: We sought to determine genes whose expression changed upon treatment with a selective inhibitor of class I PI3 kinase. Total of 6 samples: cells were treated with GDC-0941 at a concentration of 1mM for 6 hours (3 replicates) and control (3 replicates)

ORGANISM(S): Homo sapiens

SUBMITTER: O'Brien C

PROVIDER: S-ECPF-GEOD-20719 | biostudies-other | 2010 Jul

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Similar Datasets

Gene expression changes upon treatment of T47D breast cancer cells with the Pan-PI3 kinase inhibitor GDC-0941

Project description:We sought to determine genes whose expression changed upon treatment with a selective inhibitor of class I PI3 kinase. Total of 6 samples: cells were treated with GDC-0941 at a concentration of 1mM for 6 hours (3 replicates) and control (3 replicates)

2010-06-08 | E-GEOD-20719 | biostudies-arrayexpress

Gene expression changes upon treatment of T47D breast cancer cells with the Pan-PI3 kinase inhibitor GDC-0941

Project description:We sought to determine genes whose expression changed upon treatment with a selective inhibitor of class I PI3 kinase.

2010-05-25 | GSE20719 | GEO

Characterization and phase I study of CLR457, an orally bioavailable pan-class I PI3-kinase inhibitor.

Project description: Not available

| S-EPMC6440935 | biostudies-literature

Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases.

Project description: Not available

| S-EPMC6827829 | biostudies-literature

The anti-ErbB2 antibody H2-18 and the pan-PI3K inhibitor GDC-0941 effectively inhibit trastuzumab-resistant ErbB2-overexpressing breast cancer.

Project description: Not available